TABLE OF CONTENTS

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Human Vaccine Adjuvants Market - Key Market Dynamics

4.1 North America Human Vaccine Adjuvants Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Rising Prevalence of Chronic Diseases

4.2.2 Growing Focus on Immunization Programs

4.3 Market Restraints

4.3.1 Manufacturing Complexities and Regulatory Challenges

4.4 Market Opportunities

4.4.1 Growing Pharmaceutical Industry

4.5 Future Trends

4.5.1 Rising Trend of Personalized Vaccines

4.6 Impact of Drivers and Restraints:

5. Human Vaccine Adjuvants Market - North America Market Analysis

5.1 North America Human Vaccine Adjuvants Market Revenue (US$ Million), 2020 - 2030

5.2 North America Human Vaccine Adjuvants Market Forecast Analysis

6. North America Human Vaccine Adjuvants Market Analysis - by Type

6.1 Particulate Adjuvant

6.1.1 Overview

6.1.2 Particulate Adjuvant: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.2 Emulsion Adjuvant

6.2.1 Overview

6.2.2 Emulsion Adjuvant: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Combination Adjuvant

6.3.1 Overview

6.3.2 Combination Adjuvant: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Human Vaccine Adjuvants Market Analysis - by Application

7.1 Influenza

7.1.1 Overview

7.1.2 Influenza: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Hepatitis

7.2.1 Overview

7.2.2 Hepatitis: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Human papilloma virus (HPV)

7.3.1 Overview

7.3.2 Human papilloma virus (HPV): North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Human Vaccine Adjuvants Market Analysis - by End User

8.1 Pharmaceutical and Biotechnology Companies

8.1.1 Overview

8.1.2 Pharmaceutical and Biotechnology Companies: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8.2 CMOs and CROs

8.2.1 Overview

8.2.2 CMOs and CROs: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Others

8.3.1 Overview

8.3.2 Others: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Human Vaccine Adjuvants Market - Country Analysis

9.1 North America

9.1.1 North America Human Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

9.1.1.1 US Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.1 US Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.1.2 US Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.1.3 US Human Vaccine Adjuvants Market Breakdown, by End User

9.1.1.2 Canada Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.1 Canada Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.2.2 Canada Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.2.3 Canada Human Vaccine Adjuvants Market Breakdown, by End User

9.1.1.3 Mexico Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.1 Mexico Human Vaccine Adjuvants Market Breakdown, by Type

9.1.1.3.2 Mexico Human Vaccine Adjuvants Market Breakdown, by Application

9.1.1.3.3 Mexico Human Vaccine Adjuvants Market Breakdown, by End User

10. Industry Landscape

10.1 Overview

11. Company Profiles

11.1 Novartis AG

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Dynavax Technologies Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 CSL Ltd

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Seppic SA

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 SPI Pharma Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Hawaii Biotech Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Croda International Plc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Novavax Inc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Phibro Animal Health Corp

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Creative Biolabs Inc

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

List of Tables

Table 1. North America Human Vaccine Adjuvants Market Segmentation

Table 2. North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Type

Table 4. North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 5. North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million) - by End User

Table 6. US Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 7. US Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 8. US Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. Canada Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 10. Canada Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 11. Canada Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 12. Mexico Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 13. Mexico Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 14. Mexico Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. Recent Growth Strategies in the Human Vaccine Adjuvants Market

Table 16. Glossary of Terms, Human Vaccine Adjuvants Market

List of Figures

Figure 1. North America Human Vaccine Adjuvants Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. North America Human Vaccine Adjuvants Market Revenue (US$ Million), 2022 - 2030

Figure 4. North America Human Vaccine Adjuvants Market Share (%) - by Type (2022 and 2030)

Figure 5. Particulate Adjuvant: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Emulsion Adjuvant: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Combination Adjuvant: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. North America Human Vaccine Adjuvants Market Share (%) - by Application (2022 and 2030)

Figure 10. Influenza: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Hepatitis: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Human papilloma virus (HPV): North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Others: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. North America Human Vaccine Adjuvants Market Share (%) - by End User (2022 and 2030)

Figure 15. Pharmaceutical and Biotechnology Companies: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. CMOs and CROs: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Others: North America Human Vaccine Adjuvants Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. North America Human Vaccine Adjuvants Market Breakdown, by Key Countries - Revenue (2022) (US$ Million)

Figure 19. North America Human Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 20. US Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)

Figure 21. Canada Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)

Figure 22. Mexico Human Vaccine Adjuvants Market - Revenue and Forecast to 2030(US$ Million)